Glucose Health, Inc.
GLUC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $5 | $9 | $21 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $5 | $8 | $20 |
| Revenue | $0 | $1 | $1 | $1 |
| % Growth | -28.2% | -50.1% | 12.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 19.7% | 40.3% | 42.6% | 43% |
| EBITDA | -$0 | -$0 | -$1 | -$0 |
| % Margin | -79.5% | -78.9% | -52.4% | -35.2% |
| Net Income | -$0 | -$0 | -$1 | -$0 |
| % Margin | -82.3% | -78.9% | -52.4% | -35.5% |
| EPS Diluted | -0.025 | -0.029 | -0.045 | -0.026 |
| % Growth | 13.9% | 35.2% | -72.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |